Início/Ações/SCYX

SCYX

USD

SCYNEXIS Inc. Common Stock

$0.640-0.010 (-1.538%)

Preço em tempo real

Healthcare

Drug Manufacturers - Specialty & Generic

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$0.650

Máximo

$0.650

Mínimo

$0.620

Volume

0.34M

Fundamentos da empresa

Capitalização de mercado

27.0M

Setor

Drug Manufacturers - Specialty & Generic

País

United States

Estatísticas de negociação

Volume médio

0.43M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $0.62Atual $0.640Máximo $1.49

Notícias relacionadas

28/10/2025 · 12:41

Analyst Upgrades

Guggenheim Maintains Buy on SCYNEXIS, Lowers Price Target to $3

Guggenheim analyst Vamil Divan maintains SCYNEXIS with a Buy and lowers the price target from $4 to $3.

Ver mais

Guggenheim Maintains Buy on SCYNEXIS, Lowers Price Target to $3

15/10/2025 · 12:00

GlobeNewswire

SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study

SCYNEXIS to receive a $22 million payment as part of the resolution related to the restart of the Phase 3 MARIO study on invasive candidiasisScynexis will promptly wind-down and terminate the MARIO studyThe payment from

Ver mais

SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study

Ações relacionadas

CCNEP

CNB Financial Corporation Depositary Shares each representing a 1/40th ownership interest in a share of 7.125% Series A Fixed-Rate Non-Cumulative Perpetual Preferred Stock

NASDAQ

Grandes Bancos